Alps Advisors Inc. Acquires 4,995 Shares of Taro Pharmaceutical Industries Ltd. (TARO)

Alps Advisors Inc. raised its stake in shares of Taro Pharmaceutical Industries Ltd. (NYSE:TARO) by 12.5% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 44,893 shares of the company’s stock after purchasing an additional 4,995 shares during the quarter. Alps Advisors Inc. owned approximately 0.11% of Taro Pharmaceutical Industries worth $4,701,000 at the end of the most recent reporting period.

Other institutional investors also recently modified their holdings of the company. Aperio Group LLC grew its position in shares of Taro Pharmaceutical Industries by 6.4% in the 4th quarter. Aperio Group LLC now owns 55,266 shares of the company’s stock worth $5,787,000 after buying an additional 3,300 shares during the period. Highstreet Asset Management Inc. grew its position in shares of Taro Pharmaceutical Industries by 62.0% in the 4th quarter. Highstreet Asset Management Inc. now owns 5,865 shares of the company’s stock worth $614,000 after buying an additional 2,244 shares during the period. Parametrica Management Ltd purchased a new stake in shares of Taro Pharmaceutical Industries in the 4th quarter worth about $306,000. LMR Partners LLP purchased a new stake in shares of Taro Pharmaceutical Industries in the 4th quarter worth about $3,246,000. Finally, APG Asset Management N.V. grew its position in shares of Taro Pharmaceutical Industries by 1.2% in the 4th quarter. APG Asset Management N.V. now owns 226,200 shares of the company’s stock worth $19,725,000 after buying an additional 2,700 shares during the period. 11.54% of the stock is currently owned by institutional investors and hedge funds.

Shares of Taro Pharmaceutical Industries Ltd. (TARO) opened at $100.32 on Friday. The firm has a market cap of $4,037.87, a PE ratio of 19.48 and a beta of 0.62. Taro Pharmaceutical Industries Ltd. has a 1 year low of $93.01 and a 1 year high of $128.46.

ILLEGAL ACTIVITY NOTICE: “Alps Advisors Inc. Acquires 4,995 Shares of Taro Pharmaceutical Industries Ltd. (TARO)” was originally reported by The Lincolnian Online and is the property of of The Lincolnian Online. If you are viewing this news story on another site, it was illegally copied and republished in violation of international copyright law. The legal version of this news story can be viewed at https://www.thelincolnianonline.com/2018/02/24/alps-advisors-inc-boosts-position-in-taro-pharmaceutical-industries-ltd-taro-updated.html.

Taro Pharmaceutical Industries Profile

Taro Pharmaceutical Industries Ltd. (Taro) is a science-based pharmaceutical company. The Company operates principally through three entities: Taro Pharmaceutical Industries Ltd. (Taro Israel), and two of its subsidiaries, Taro Pharmaceuticals Inc (Taro Canada) and Taro U.SA The Company markets over 200 pharmaceutical products in over 25 countries.

Institutional Ownership by Quarter for Taro Pharmaceutical Industries (NYSE:TARO)

Receive News & Ratings for Taro Pharmaceutical Industries Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Taro Pharmaceutical Industries and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply